Research across Influenza
Related studies from across the Influenza family.
Toll-like receptor signaling governs inflammatory phenotypes and progression in infectious myocarditis
Toll-like receptors shape severity of infectious myocarditis
This systematic review examines the role of toll-like receptors (TLRs) in infectious myocarditis associated with COVID-19, influenza, and se…
A systematic review finds that pathogen-specific TLR signaling determines inflammation and outcomes in infectious myocarditis, with COVID-19…
Respiratory viral coinfections reshape immune signaling and granuloma stability in Mycobacterium tuberculosis infections
Viral Infections May Change How the Body Fights Tuberculosis
This narrative review synthesizes how respiratory viruses, including SARS-CoV-2 and influenza, impact host immune signaling and granuloma eq…
Research shows that common respiratory viruses like flu or COVID-19 can change how the immune system responds to tuberculosis infections.
Many healthcare students lack knowledge that antibiotics do not speed recovery from colds and flu
Healthcare students often lack clear knowledge on antibiotics and viruses
This meta-analysis of 131 studies from 43 countries found that while 88.7% of healthcare students correctly knew antibiotics treat bacterial…
Many healthcare students are unsure if antibiotics can treat common colds or flu, which may lead to improper use of these important medicine…
TCM influenza research surges after 2020, shifting from clinical practice to mechanistic studies
Traditional Chinese Medicine Research on Influenza Surges After 2020
A systematic bibliometric analysis of 1,527 publications maps the landscape of Traditional Chinese Medicine (TCM) research on influenza. The…
A review of 1,527 publications shows TCM research for influenza has grown rapidly since 2014, with a sharp rise after 2020. China leads in o…
Synergistic Effects of Prior Influenza and COVID-19 Vaccination on Future Vaccine Uptake
Prior Flu Vaccines May Increase Willingness to Get COVID Shots
Meta-analysis data suggests that prior experience with influenza vaccines significantly boosts patient willingness to receive COVID-19 vacci…
People who have received flu vaccines in the past show a higher willingness and likelihood to get vaccinated against COVID-19.
High-dose quadrivalent influenza vaccine shows non-inferior immunogenicity in Chinese children aged 6 to 35 months
High-dose flu shots show greater protection for young children in China
This randomized, double-blind study in 3,000 Chinese children aged 6 to 35 months found an investigational high-dose quadrivalent influenza …
A new study in China shows high-dose flu vaccines work as well as or better than standard shots for toddlers, offering stronger protection a…
Review of influenza A and secondary bacterial infections identifies critical knowledge gaps
Review highlights gaps in flu and secondary infection care
This is a narrative review on influenza A virus infection, secondary bacterial infection, and nosocomial infection. The authors synthesize c…
A new review points out major missing knowledge about flu and related infections. It calls for more research to help patients.
Systematic review compares viral and bacterial pathogen mechanisms in respiratory infections
Understanding how different germs hurt lungs helps doctors treat patients better and faster today
This systematic review synthesizes evidence regarding receptor recognition, cellular injury, and immunopathological mechanisms across SARS-C…
This review explains how three common germs damage human cells in unique ways. Knowing these differences helps doctors predict sickness and …
mRNA-1010 shows superior efficacy against influenza in older adults
New flu shot cuts illness by 27 percent in adults over 50
A phase 3 trial found mRNA-1010 vaccine had 26.6% relative efficacy versus standard comparator in adults 50+.
A new mRNA flu vaccine reduced confirmed flu illness by 27 percent compared with the standard shot in adults 50 and older.
Six H5N1 vaccine formulations showed immunogenicity and acceptable safety in 420 healthy children aged 6 months to 9 years
Higher adjuvant content boosts immunity in children without added safety risks
This phase 2, observer-blind, multicenter study evaluated six formulations of MF59-adjuvanted H5N1 vaccine in 420 healthy infants and childr…
A Phase 2 trial in healthy children found that higher adjuvant content improved immune responses to an H5N1 vaccine without increasing side …
Systematic review and meta-analysis finds bacterial co-infection in 17.3% of hospitalized influenza patients
Hospital data shows high rates of bacterial co-infection in influenza patients
This systematic review and meta-analysis of 111,889 hospital-attended patients with laboratory-confirmed influenza found a pooled prevalence…
Analysis of over 111,000 patients reveals that bacterial co-infection occurs in 17.3% of hospital cases with confirmed influenza infection.
Coadministration of RSV mRNA vaccine and high-dose flu vaccine noninferior for flu but not for RSV in older adults
New data shows RSV and flu shots work well together
This phase 3 randomized controlled trial in 1900 adults aged 65 and older compared coadministration of mRNA-1345 and quadrivalent influenza …
Older adults can now get their RSV and flu vaccines during one visit without safety risks or extra trips to the clinic for care.